News & Events

Onconox Welcomes Geoff Muckle as Interim CEO

Onconox is thrilled to announce the appointment of Geoff Muckle as Interim CEO. With over 20 years of experience in oncology innovation and pharmaceutical leadership, Geoff will drive the company’s growth and development.

Dr. Justin Stebbing Joins The Team

Onconox recruited high profile and internationally reputed Oncologist Dr. Justin Stebbing to the board.

Onconox Achieves Milestone In Funding Round

Onconox successfully closed seed round that will bring the lead program to the clinic.